PHASE-II EVALUATION AND PLASMA PHARMACOKINETICS OF HIGH-DOSE INTRAVENOUS 6-THIOGUANINE IN PATIENTS WITH COLORECTAL-CARCINOMA

被引：18

作者：

KONITS, PH

EGORIN, MJ

VANECHO, DA

AISNER, J

ANDREWS, PA

MAY, ME

BACHUR, NR

WIERNIK, PH

机构：

[1] UNIV MARYLAND HOSP,BALTIMORE CANC RES CTR,MED ONCOL SECT,BALTIMORE,MD 21201

[2] UNIV MARYLAND HOSP,BALTIMORE CANC RES CTR,CLIN BIOCHEM LAB,BALTIMORE,MD 21201

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1982年 / 8卷 / 02期

关键词：

D O I：

10.1007/BF00255484

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：199 / 203

页数：5

共 10 条

[1]

ANDREWS PA, 1982, J CHROMATOGR, V227, P83

[2]

DENES A, 1979, P AM ASS CANCER RES, V19, P107

[3] HEMATURIA AND CRYSTALLURIA AFTER HIGH-DOSE 6-MERCAPTOPURINE ADMINISTRATION [J].

DUTTERA, MJ ;

CAROLLA, RL ;

GULLION, DS ;

GALLELLI, JF ;

KEIM, DE ;

HENDERSON, ES .

NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (06) :292-+

[4]

ELION G. B., 1962, CANCER CHEMOTHER REPTS, V16, P197

[5]

HASKELL CM, 1980, CANCER TREATMENT, P91

[6]

HORTON J, 1975, CANCER CHEMOTH REP 1, V59, P333

[7]

LEPAGE GA, 1971, CANCER RES, V31, P1627

[8]

MORTEL CG, 1976, CLIN GASTROENTEROL, V5, P777

[9]

PRESANT CA, 1980, CANCER TREAT REP, V64, P1109

[10]

Woolley P V 3rd, 1976, Semin Oncol, V3, P415

← 1 →